Impact of Side-effects of Atypical Antipsychotics on Non-compliance, Relapse and Cost

By Mortimer A   Williams P   Meddis D  

The Journal of International Medical Research, Vol. 31, Iss. 3, 2003-05 ,pp. : 188-196

Field House Publishing

Access to resources Recommend Favorite

Accounting for Noncompliance in Pharmacoeconomic Evaluations

By Hughes D.A.   Bagust A.   Haycox A.   Walley T.  

PharmacoEconomics, Vol. 19, Iss. 12, 2001-01 ,pp. : 1185-1197

Adis International

Access to resources Recommend Favorite

Estimation of Population Pharmacokinetic Parameters in the Presence of Non-compliance

By Mu Song   Ludden Thomas M.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 30, Iss. 1, 2003-02 ,pp. : 53-81

Springer Publishing Company

Access to resources Recommend Favorite

The pharmacoeconomic impact of generics: an evolutionary tale

By Smethurst Dominic  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. : 1235-1238

Informa Healthcare

Access to resources Recommend Favorite

A Pharmacoeconomic Evaluation of Statins in the Treatment of Hypercholesterolaemia in the Primary Care Setting in Spain

By Tárraga-López Pedro J.  

PharmacoEconomics, Vol. 23, Iss. 3, 2005-01 ,pp. : 275-287

Adis International

Access to resources Recommend Favorite